GO:1990851 Wnt-Frizzled-LRP5/6 complex: Components, Assembly and Research Methods

Research-grade guide for scientists and biopharma professionals

Key Takeaways

GO:1990851 describes the Wnt-Frizzled-LRP5/6 complex, a trimeric receptor assembly of a secreted Wnt ligand, a Frizzled (Fz) receptor, and the co-receptor LRP5 or LRP6.
This complex is the primary signal-receiving unit of canonical Wnt/beta-catenin signaling, which controls cell fate, proliferation, and stemness.
Assembly occurs at the plasma membrane and requires simultaneous binding of Wnt to Fz and LRP5/6, which promotes LRP6 phosphorylation and downstream pathway activation.
The complex is antagonized by secreted inhibitors such as Dickkopf (Dkk) proteins, which disrupt Wnt-Fz-LRP5/6 ternary complex formation.
Dysregulation of the complex is linked to cancer, bone disease, and developmental disorders, making it a major therapeutic target.
CRISPR knockout, point-mutation, knock-in, and overexpression models enable precise interrogation of each component in the complex.

Description

The Wnt-Frizzled-LRP5/6 complex (GO:1990851) is a cell-surface protein assembly that forms when a secreted Wnt ligand binds simultaneously to a Frizzled (Fz) receptor and to the co-receptor low density lipoprotein receptor-related protein 5 (LRP5) or LRP6. This ternary complex is the initiating event of canonical Wnt/beta-catenin signaling, a pathway that governs embryonic development, tissue homeostasis, and stem cell maintenance. Because the complex sits at the top of the signaling cascade, its composition and assembly are decisive for whether cells proliferate, differentiate, or remain quiescent. Researchers study GO:1990851 to understand how extracellular Wnt cues are converted into intracellular transcriptional responses. The complex is not a static structure; it is dynamically assembled and disassembled at the plasma membrane, and its activity is modulated by secreted antagonists such as Dickkopf (Dkk) proteins. This regulation makes the complex a focal point for developmental biology, oncology, and regenerative medicine. From a methodological standpoint, the Wnt-Frizzled-LRP5/6 complex can be interrogated with CRISPR-based genome editing, biochemical crosslinking, and live-cell imaging. Understanding which genes contribute to complex formation and signaling is essential for building accurate disease models and for identifying druggable nodes in the pathway.

Wnt-Frizzled-LRP5/6 complex At A Glance

GO ID GO:1990851
GO term Wnt-Frizzled-LRP5/6 complex
Ontology cellular_component
Synonym Frizzled-LRP5/6 complex; Fz/Wnt/LRP6 complex; Wnt-FZD-LRP5/6 trimeric complex; WNT-FZD-LRP5 complex; WNT-FZD-LRP6 complex; Wnt.Fz.LRP ternary complex; Wnt-induced Frizzled-LRP5/6 complex; Wnt receptor complex
Major function Receives secreted Wnt ligands and initiates canonical Wnt/beta-catenin signal transduction
Cellular location Plasma membrane
Key components Wnt ligand, Frizzled receptor, LRP5 or LRP6 co-receptor
Regulation Antagonized by secreted Dickkopf (Dkk) proteins
Associated pathway Canonical Wnt/beta-catenin signaling

What Is GO:1990851?

GO:1990851, the Wnt-Frizzled-LRP5/6 complex, is defined as a protein complex containing a secreted Wnt protein associated with its receptor Frizzled (Fz) and the co-receptor LRP5 or LRP6. In other words, it is the ligand-bound, trimeric receptor unit that receives Wnt signals at the cell surface and transmits them into the canonical Wnt/beta-catenin pathway. The complex is also known by synonyms such as Frizzled-LRP5/6 complex, Wnt-FZD-LRP5/6 trimeric complex, and Wnt receptor complex.

Why Is Wnt-Frizzled-LRP5/6 complex Important in Cell Biology?

The Wnt-Frizzled-LRP5/6 complex is important because it is the entry point for canonical Wnt signaling, a pathway that controls cell proliferation, differentiation, and stem cell self-renewal. Without proper assembly of this trimeric complex, Wnt signals cannot be transmitted, leading to developmental defects and tissue homeostasis failures. Because the complex is extracellularly exposed, it is also a prime target for therapeutic antibodies and small-molecule inhibitors. Understanding its regulation by antagonists such as Dickkopf proteins provides a framework for modulating Wnt activity in disease.
Initiates canonical Wnt/beta-catenin signaling, a core developmental pathway.
Controls stem cell maintenance and tissue regeneration.
Dysregulation is implicated in multiple cancers, including colorectal and breast cancer.
Mutations affecting LRP5/6 are linked to bone density disorders.
Secreted antagonists such as Dkk proteins modulate complex formation and are potential therapeutics.
The complex is a target for drug discovery in oncology and regenerative medicine.
CRISPR models of complex components help dissect gene function in vivo.
Understanding complex assembly informs synthetic biology and pathway engineering.

Structure and Composition of Wnt-Frizzled-LRP5/6 complex

Wnt ligand binding to Frizzled
In simple terms: A Wnt protein grabs onto a Frizzled receptor on the cell surface.
The first step in forming the Wnt-Frizzled-LRP5/6 complex is the binding of a secreted Wnt ligand to the extracellular cysteine-rich domain of a Frizzled (Fz) receptor. This interaction is specific and is required for subsequent recruitment of the LRP5/6 co-receptor. Wnt proteins are lipid-modified, which influences their secretion and binding properties.
Recruitment of LRP5/6 co-receptor
In simple terms: The Wnt-Frizzled pair then grabs LRP5 or LRP6 to form a three-part receptor complex.
After Wnt binds Fz, the co-receptor LRP5 or LRP6 is recruited into the complex, forming a trimeric Wnt-Fz-LRP5/6 assembly. This step is essential for canonical signaling because LRP6 phosphorylation and downstream signalosome assembly depend on its inclusion in the complex. The complex is stabilized by direct protein-protein interactions between Wnt, Fz, and LRP5/6.
Membrane organization and signalosome formation
In simple terms: The receptor complex clusters at the membrane and triggers a chain of signals inside the cell.
Once assembled, the Wnt-Frizzled-LRP5/6 complex promotes the phosphorylation of LRP6 and the recruitment of intracellular proteins such as Dishevelled, leading to beta-catenin stabilization. The complex is thought to reside in specialized membrane microdomains that facilitate signaling. This organization ensures efficient signal transduction from the cell surface to the nucleus.
Antagonism by Dickkopf proteins
In simple terms: Inhibitor proteins like Dkk can block the complex from forming.
Secreted Dickkopf (Dkk) proteins antagonize Wnt signaling by binding to LRP5/6 and preventing the formation of the Wnt-Frizzled-LRP5/6 ternary complex. This inhibition is a key regulatory mechanism in development and disease. The balance between Wnt ligands and Dkk antagonists determines the level of pathway activity.

Key Genes Involved in GO:1990851 Wnt-Frizzled-LRP5/6 complex

The following genes and proteins are core components or regulators of the Wnt-Frizzled-LRP5/6 complex and are commonly studied in functional genomics research.
GeneMajor RoleResearch Relevance
WNT3ASecreted Wnt ligand that binds Frizzled and LRP5/6Commonly used to activate canonical Wnt signaling in cell culture
WNT1Secreted Wnt ligand involved in development and cancerModeled in knockout and overexpression studies
FZD1Frizzled receptor that binds Wnt ligandsTarget for receptor-level perturbation
FZD2Frizzled receptor family memberStudied in developmental signaling
FZD4Frizzled receptor involved in vascular developmentRelevant to angiogenesis research
FZD5Frizzled receptor that mediates Wnt signalingUsed in receptor specificity studies
FZD7Frizzled receptor implicated in cancer stemnessTarget for cancer research
LRP5Co-receptor for Wnt ligandsMutations linked to bone density disorders
LRP6Co-receptor essential for canonical Wnt signalingKey node for pathway activation and phosphorylation studies
DKK1Secreted antagonist of Wnt-Frizzled-LRP5/6 complexUsed to inhibit Wnt signaling experimentally
DKK2Secreted antagonist with context-dependent rolesStudied in development and bone biology
DVL1Intracellular scaffold recruited to the complexLinks receptor activation to downstream events
DVL2Dishevelled family member involved in signalosome assemblyCommonly knocked out to block Wnt signaling
CTNNB1Beta-catenin, the key effector of canonical Wnt signalingReadout for complex activity
AXIN1Scaffold protein in the beta-catenin destruction complexModulates pathway output
APCNegative regulator of beta-cateninFrequently mutated in colorectal cancer
GSK3BKinase that phosphorylates beta-cateninTarget for pathway modulation

How Is Wnt-Frizzled-LRP5/6 complex Regulated?

The Wnt-Frizzled-LRP5/6 complex is regulated at multiple levels. Extracellularly, secreted Dickkopf (Dkk) proteins bind LRP5/6 and prevent ternary complex formation, thereby inhibiting canonical Wnt signaling. Intracellularly, phosphorylation of LRP6 and recruitment of Dishevelled are critical for signal propagation. The availability of Wnt ligands, Frizzled receptors, and LRP5/6 co-receptors at the cell surface also determines complex assembly and activity. Feedback regulation by pathway target genes further tunes the strength and duration of signaling.

Wnt-Frizzled-LRP5/6 complex and Human Disease

GeneDisease / BiologyPotential Experimental Model
LRP5Bone density disordersKnockout or point-mutation cell lines
LRP6Metabolic and developmental defectsKnock-in of patient variants
DKK1Cancer and bone diseaseOverexpression or knockout models
FZD7Cancer stemnessKnockout and overexpression in cancer cell lines
CTNNB1Colorectal cancer and othersPoint mutation knock-in to mimic activation
Cancer
Dysregulation of the Wnt-Frizzled-LRP5/6 complex is frequently observed in human cancers, where aberrant activation of canonical Wnt signaling drives proliferation and survival. Overexpression of Wnt ligands or Frizzled receptors, or loss of antagonists such as Dkk, can lead to constitutive pathway activity. Colorectal cancer is a classic example, often involving mutations downstream of the complex, but upstream components are also implicated in other tumor types.
Bone and skeletal disorders
LRP5 and LRP6 are critical for bone homeostasis, and mutations affecting their function or regulation can alter bone mineral density. The Wnt-Frizzled-LRP5/6 complex therefore represents a therapeutic target for osteoporosis and related skeletal conditions. Dkk proteins, as antagonists of the complex, are also studied in this context.
Developmental disorders
Because the complex is essential for embryonic development, disruptions in Wnt, Frizzled, or LRP5/6 function can cause congenital defects. Animal models with mutations in complex components display patterning abnormalities and organ malformations. Studying these models helps link genotype to phenotype.

From Wnt-Frizzled-LRP5/6 complex-Related Genes to Experimental Models

Research QuestionSuitable Model
Does loss of LRP6 abolish Wnt signaling?LRP6 knockout cell line
Does a specific LRP6 phosphorylation site matter?Point-mutation knock-in of LRP6
Can a tagged Frizzled receptor track complex assembly?Tagged knock-in of FZD
Does overexpression of Wnt ligand activate the pathway?Wnt overexpression cell line
Does Dkk1 block complex formation?DKK1 overexpression or recombinant protein treatment
Which Frizzled receptors mediate a specific response?CRISPR library screening of FZD genes

How to Study the Wnt-Frizzled-LRP5/6 complex Process

MethodWhat It MeasuresTypical Application
Co-immunoprecipitationProtein-protein interactionsValidate complex assembly
Live-cell imagingSpatiotemporal dynamicsTrack receptor recruitment
Luciferase reporter assayWnt/beta-catenin transcriptional activityFunctional readout of complex activation
CRISPR knockout screeningGene essentiality for pathway activityIdentify novel regulators
Phospho-specific western blotLRP6 phosphorylation statusMeasure complex activation
Proximity ligation assayIn situ protein interactionsDetect complex formation in fixed cells
RNA-seqTranscriptional changesGlobal downstream effects
Surface biotinylationPlasma membrane localizationAssess receptor availability
Biochemical co-immunoprecipitation
Co-immunoprecipitation followed by western blotting can detect physical interactions between Wnt, Frizzled, and LRP5/6, confirming assembly of the complex. This method is useful for validating complex formation under different conditions.
Live-cell imaging
Fluorescently tagged components can be imaged in live cells to visualize the spatiotemporal dynamics of Wnt-Frizzled-LRP5/6 complex assembly at the plasma membrane. This approach reveals real-time recruitment and internalization events.
Transcriptional reporter assays
Wnt-responsive luciferase reporters measure downstream beta-catenin activity, providing a functional readout of complex activation. These assays are widely used to test the impact of mutations or drugs.
CRISPR-based genetic screens
Genome-wide CRISPR knockout screens can identify genes that regulate Wnt-Frizzled-LRP5/6 complex function and pathway activity. Such screens are powerful for discovering novel modulators.

How CRISPR Can Be Used to Study GO:1990851 Wnt-Frizzled-LRP5/6 complex

Knockout

CRISPR knockout of genes encoding Wnt, Frizzled, or LRP5/6 components can abolish Wnt-Frizzled-LRP5/6 complex formation and downstream signaling, providing causal evidence for their roles. Knockout cell lines are valuable for testing pathway dependency and for drug sensitivity studies.

Point Mutation

Point mutations can be introduced into LRP5/6 or Frizzled to mimic patient variants or to disrupt specific phosphorylation sites, allowing precise structure-function analysis of the complex. Such models help distinguish between loss-of-function and gain-of-function mechanisms.

Knock-in

Knock-in of fluorescent or affinity tags into endogenous loci enables tracking of complex components at physiological expression levels. Tagged knock-in models are ideal for imaging and proteomic studies of the Wnt-Frizzled-LRP5/6 complex.

Overexpression

Overexpression of Wnt ligands, Frizzled receptors, or LRP5/6 can constitutively activate the complex and downstream pathway, modeling oncogenic or developmental hyperactivation. Overexpression systems are also used to study antagonist resistance.

How EDITGENE Supports Wnt-Frizzled-LRP5/6 complex Research

Researchers studying Wnt-Frizzled-LRP5/6 complex-related genes often need to determine whether a candidate gene is causally involved in complex assembly, signaling output, or disease phenotypes. EDITGENE provides a comprehensive suite of CRISPR-based services to generate precisely engineered cell models for such investigations.
Contact EDITGENE today to design your custom CRISPR model for Wnt-Frizzled-LRP5/6 complex research.

Frequently Asked Questions About Wnt-Frizzled-LRP5/6 complex

It is a cell-surface protein complex consisting of a secreted Wnt ligand bound to a Frizzled receptor and the co-receptor LRP5 or LRP6, which initiates canonical Wnt/beta-catenin signaling.
Key genes include WNT ligands, FZD receptors, LRP5, LRP6, and regulators such as DKK1 and DVL.
GO:1990851 represents the receptor complex that receives Wnt signals and activates downstream beta-catenin-dependent transcription.
It assembles at the plasma membrane of Wnt-responsive cells.
It is regulated by secreted antagonists like Dickkopf proteins, which prevent complex formation, and by intracellular phosphorylation events.
Dysregulation is linked to cancer, bone density disorders, and developmental defects.
CRISPR knockout, point mutation, knock-in, and overexpression models allow precise manipulation of complex components to test their function.
Common methods include co-immunoprecipitation, live-cell imaging, luciferase reporter assays, and CRISPR screens.
Synonyms include Frizzled-LRP5/6 complex, Wnt-FZD-LRP5/6 trimeric complex, and Wnt receptor complex.
Aberrant activation of this complex can drive tumor cell proliferation and survival, making it a therapeutic target.

Conclusion

The Wnt-Frizzled-LRP5/6 complex (GO:1990851) is a central signaling hub that translates extracellular Wnt cues into intracellular responses. Its assembly, regulation, and downstream effects are critical for development, tissue homeostasis, and disease. Understanding this complex through CRISPR-based models and biochemical methods offers opportunities for therapeutic intervention in cancer, bone disorders, and beyond.

References

  1. 1. Zorn AM. 2001. Wnt signalling: antagonistic Dickkopfs.. Curr Biol 11(15):R592-5 PMID: 11516963
Contact Us
*
*
*
*
How did you hear about us: